112225 ⎘
Nucleic acids vectors Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
REVERSIBLY IMMORTALIZED HEPATOCYTES AND METHODS OF USE
#602Process for the removal of selectable marker gene sequences
#603VEGF Receptor Conditional Knockout Animals and Methods of Use
#604Use of VEGF and homologues to treat neuron disorders
#605Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications thereof
#606Modular genomes for synthetic biology and metabolic engineering
#607O-GLYCANS IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND CANCERS
#608Vertebrate embryonic pattern-inducing proteins, and uses related thereto
#609Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#610Cell and transgenic animal modelling human antigenic presentation and their uses
#611Transgenic animals and methods of monitoring hedgehog responding cells
#612Methods and compositions relating to restricted expression lentiviral vectors and their applications
#613Method For Constructing Recombinant Herpes Simplex Virus
#614Production of a transgenic avian by cytoplasmic injection
#615Transgenic mice containing TRP gene disruptions
#616Self-rearranging DNA vectors
#617Transgenic mice containing Lrp5 gene disruptions
#618Methods for producing minus-strand RNA viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken β-actin promoter
#619Flp-mediated recombination
#620Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration
#621Method for producing immortalised antibodies-secreting cells
#622Recombinase-Based System for Expression of Foreign Proteins Using Adenovirus Vectors
#623Transgenic avians containing recombinant ovomucoid promoters
#624Minus strand rna virus vector carrying gene modified in high mutation region
#625Method for creating fusion protein and conditional alleles
#626Transgenic mouse having an amyloid precursor protein with a modified beta secretase cleavage site
#627Transgenic non-human animals for pharmacological and toxicological studies
#628Production of humanized antibodies in transgenic animals
#629Kits for multiple non-cross reacting recombination reactions utilizing loxP sequences
#630Altered recombinases for genome modification
#631Gutless adenovirus vector and the construction method thereof
#632Transgenic Mice Containing GPCR5-1 Gene Disruptions
#633Double-muscling in mammals
#634Methods for producing microRNAs
#635Methods of modulating bone growth, bone remodeling and adiposity
#636BMP pathway methods and compositions
#637Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same
#638HUNTINGTIN INTERACTING PROTEIN GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO
#639Proliferator-Activated Receptor Disruptions, Compositions and Methods Relating Thereto
#640Method of preparing transgenic organism with use of methylation and system therefor
#641Adenovirus vectors comprising meganuclease-type endonucleases, and related systems
#642Paramyxovirus-derived RNP
#643Genetic screen in drosophila for metastatic behavior
#644Efficient generation of expression cell lines through the use of scorable homeostatic reporter genes
#645Mediators of epithelial adhesion and their role in cancer and skin disorders
#646Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#647Cathepsin G (CTSG) Disruptions, Compositions and Methods Relating Thereto
#648Self-assembling recombinant papillomavirus capsid proteins
#649Sequence of natural or synthetic retroelements enabling nucleotide sequence insertion into a eukaryotic cell
#650Gab2 (p97) gene and methods of use thereof
#651Transgenic Mice Containing Kir3.3 Potassium Channel Gene Disruptions
#652RNA polymerase III promoter, process for producing the same and method of using the same
#653Ocular gene therapy
#654Chromosome-based platforms
#655Cell-specific molecule and method for importing DNA into osteoblast nuclei
#656Inducible site-directed mutagenesis through conditional gene rescue
#657Genetically modified non-human mammals and cells
#658Method for expressing inducible rna [in cells, nucleic acid molecules therefor and cells transformed by said molecules
#659Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof
#660Circular nucleic acid vectors, and methods for making and using the same
#661Transgenic mice containing mGluR7 metabotropic glutamate receptor gene disruptions
#662Sirna mediated gene silencing in transgenic animals
#663Paramyxovirus vector encoding ribozyme and utilization thereof
#664Tr2, tr4, tr2/tr4 double knockouts and uses thereof
#665Methods of making minicircles
#666Transposon-based vectors and methods of nucleic acid integration
#667Targeted transgenesis using the rosa26 locus
#668Transgenic animal as a model for fibrotic diseases
#669Glycosylated interferon α
#670Avians that produce eggs containing exogenous proteins
#671Transgenic mice containing SOCS-5 cytokine signalling suppressor gene disruptions
#672Human artificial chromosome (hac) vector
#673Production of exogenous proteins in egg whites of transgenic chickens
#674Transgenic mice containing channel activating protease 1 (CAP1) gene disruptions
#675Transgenic mice containing deubiquitinated enzyme gene disruptions
#676Transgenic mice containing MSK2 serine/threonine kinase gene disruptions
#677Automated gene-targeting using non-toxic detectable markers
#678Tumor model with chromosomal rearrangement and uses thereof
#679Process of producing environmentally safe transgenic organisms
#680Transgenic mice containing adrenocorticotropin hormone receptor gene disruptions
#681Hcv gene transgenic animal
#682Gene trap system
#683Highly efficient gene targeting vectors and methods for gene targeting method forward epithelial cell line
#684Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions
#685Glycosylated interferon alpha obtained from a transgenic chicken
#686Transgenic mice containing lumulus clotting factor protease-like gene disruptions
#687ADAM-like protease disruptions, compositions and methods related thereto
#688Artificial human chromosome containing human antibody a light chain gene
#689GNG4 gene disruptions, compositions and methods related thereto
#690Method of screening antiobesity agents and animal model of obesity
#691Transgenic mice containing CX2 gene disruptions
#692TRP6 calcium channel disruptions, compositions and methods related thereto
#693Transgenic mice containing sulfotransferase gene disruptions
#694High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern
#695Transgenic mice containing anaphylatoxin C3a gene disruptions
#696OGR1 gene disruptions, compositions and methods relating thereto
#697Transgenic mice containing chordin gene disruptions
#698Vectors for stable gene expression
#699Disimmortalizable mammalian chromaffin cell lines for cell therapy for pain
#700Transgenic mice containing retinoid X receptor interacting protein gene disruptions
#701Protein tyrosine phosphatase RPTP-beta disruptions, compositions and methods relating thereto
#702Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
#703System producing infectious recombinant influenza virus
#704Method of performing trangenesis
#705Ungulates with genetically modified immune systems
#706Directed genetic modifications of human stem cells
#707Method of producing an exogenous protein in the egg of a chicken
#708Recombinase mediated transcription
#709Suppression of endogenous immunoglobulin expression
#710Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
#711Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
#712CYT28 serpentine receptor disruptions, compositions and methods relating thereto
#713Delta opioid receptor disruptions, compositions and methods related thereto
#714Transgenic mice containing glucocorticoid-induced receptor gene disruptions
#715Cells expressing recombinase useful for adenovirus vector production and control of gene expression
#716Immunologically privileged cells and uses thereof
#717Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto
#718Transgenic mice containing NTTP1 phosphatase gene disruptions
#719Multi-reporter gene model for toxicological screening
#720Methods of Tranducing genes into T cells
#721Transgenic mice containing beta3GalT2 gene disruptions
#722Transgenic mice containing TMEM3 beta-1,3-N-acetylglucosaminyltransferase gene disruptions
#723Transgenic mice containing CLCN4 chloride ion channel gene disruptions
#724High-efficiency wild-type-free AAV helper functions
#725DNA containing variant FRT sequences
#726Method of treatment and an animal model useful for same
#727Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions
#728Methods for the production of cells and mammals with desired genetic modifications
#729Transgenic mice containing GPCR-like gene disruptions
#730Transgenic chickens producing exogenous protein in eggs
#731Transgenic mice containing PAFR gene disruptions
#732Muir-Torre-like syndrome in Fhit deficient mice
#733Regulation of adenovirus DNA packaging by IPTG
#734Animal model for studying hormone signalling and method of modulating the signalling
#735Conditional disruption of dicer1 in cell lines and non-human mammals
#736Murine Pten null prostate cancer model
#737Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination
#738Carbohydrate determinant selection system for homologous recombination
#739Cytokine-expressing cellular vaccines for treatment of prostate cancer
#740Recombinant influenza viruses for vaccines and gene therapy
#741Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
#742Site-specific recombination systems for use in eukaryotic cells
#743Transgenic mice containing chemokine receptor 9A gene disruptions
#744Tagged epitope protein transposable element
#745Secreted protein associated with depression, compositions and methods of use thereof
#746Chromosome-based platforms
#747Integration vectors
#748Methods and products related to the production of inner ear hair cells
#749Lentiviral vectors and uses thereof
#750Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission
#751Methods of inhibiting tumor cell proliferation
#752Vectors having both isoforms of beta-hexosaminidase
#753Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same
#754High-efficiency AAV helper functions
#755Recombinase-expressing cells
#756Cre-lox based method for conditional RNA interference
#757Genomic modification
#758Non-invasive real-time in vivo bioluminescence imaging of local CaÂ2+ dynamics in living organisms
#759Therapeutic delivery of adenosine into a tissue
#760BMP pathway methods and compositions
#761Transgenic mice containing brain-specific membrane-anchored protein gene disruptions
#762Transgenic non-human animals expressing a truncated activin type II receptor
#763FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
#764Gastrointestinal proliferative factor and uses thereof
#765Gastrointestinal proliferative factor and uses thereof
#766Pluripotency determining factors and uses thereof
#767Lentiviral vectors, related reagents, and methods of use thereof
#768Transgenic aves producing human polyclonal antibodies
#769Everninomicin biosynthetic proteins
#770Compositions and methods for increasing animal size growth rate
#771Vectors with modified protease-dependent tropism
#772Therapeutic anti-cancer DNA
#773Methods of preforming homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof
#774Delivery of functional protein sequences by translocating polypeptides
#775Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
#776Genomic modification
#777Knockin non-human animal and tissue-specific MnSOD knockout non-human animal
#778Production of recombinant polypeptides by bovine species and transgenic methods
#779Pramyxovirusl vectors encoding antibody and utilization thereof
#780Chromosome-based platforms
#781Chimeric nonhuman animal
#782Avian gene expression controlling regions
#783Animal model for identifying agents that inhibit or enhance CTLA4 signaling
#784Methods and compositions for preventing obesity and obesity related disorders
#785Transgenesis with humanized immunoglobulin loci
#786Method for comprehensive identification of cell lineage specific genes
#787Animals and cells containing a mutated alpha2delta gene
#788Reversible immortalization of human renal proximal tubular epithelial cells
#789Adipocytes and uses thereof
#790Regulatable promoters for synthesis of small hairpin RNA
#791Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof
#792Isolation tool for viable c-kit expressing cells
#793Methods of examining (-) strand rna virus vectors having lowered ability to form grains and method of constructing the same
#794Somatic recombination
#795Expression of polypeptides in rod outer segment membranes
#796System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same
#797Method for targeting transcriptionally active loci
#798Use of AAV integration efficiency element for mediating site-specific integration of a transcription unit
#799Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
#800Transgenic bovines having reduced prion protein production
#801Vectors for gene mutagenesis and gene discovery
#802Expression of polypeptides in rod outer segment membranes
#803Generation of transgenic mice by transgene-mediated rescue of spermatogenesis
#804SiRNA mediated gene silencing in transgenic animals
#805HBM variants that modulate bone mass and lipid levels
#806Methods and compositions for seamless cloning of nucleic acid molecules
#807Site specific recombination in avians
#808Transgenic mice generated by transposition and uses thereof
#809Cell and transgenic animal modelling human antigenic presentation and their uses
#810Dna construct for assessing thymic function activity and therapeutical uses thereof
#811Mouse λ light chain locus
#812Vectors and methods for the mutagenesis of mammalian genes
#813DNA recombination in eukaryotic cells by the bacteriophage PHIC31 recombination system
#814Adenoviral vector system
#815Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
#816LKB1 gene knockout animals
#817Animals and cells containing a mutated alpha2/omega1 gene
#818Induction of the formation of insulin-producing cells via gene transfer of pancreatic beta-cell-associated transcriptional factor
#819Knock-in-mouse
#820Sgrf gene-modified non-human animals
#821Phenotypic effects of ubiquinone deficiencies and methods of screening thereof
#822Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy
#823Methods of inhibiting tumor cell proliferation
#824GLYT1 conditional knock-out mice
#825Transgenic animal model for cancer and stem cells
#826Deleted adenovirus vectors and methods of making and administering the same
#827Selective anesthetic agents and methods of identifying the same
#828Compositions and systems for the regulation of genes
#829Compositions and methods for the suppression of mammary epithelial cell proliferation
#830Vertebrate embryonic pattern-inducing proteins and uses related thereto
#831Genome mutation by intron insertion into an embryonic stem cell genome
#832Altered recombinases for genome modification